DCM
DTIL icon

Driehaus Capital Management’s Precision BioSciences DTIL Stock Holding History

Driehaus Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.47M Buy
995,371
+207,671
+26% +$958K 0.04% 287
2025
Q4 		$3.28M Buy
+787,700
New +$4.47M 0.02% 320

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Driehaus Capital Management's DTIL Position: Q1 2026 in Review

Driehaus Capital Management increased its Precision BioSciences (DTIL) stake by 26% in Q1 2026, buying an estimated $958K and bringing the position to 995,371 shares worth $5.47M. The position accounts for 0.04% of the portfolio, ranked #287.

Driehaus Capital Management first reported a position in DTIL in Q4 2025 and has held it in 2 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Driehaus Capital Management held 995,371 shares of Precision BioSciences worth $5.47M as of Q1 2026.
  • Driehaus Capital Management bought 207,671 Precision BioSciences shares in Q1 2026, an estimated $958K.
  • Precision BioSciences made up 0.04% of Driehaus Capital Management's portfolio in Q1 2026, its #287 holding.
  • Driehaus Capital Management first reported a position in Precision BioSciences in Q4 2025 and has held it in 2 quarters since.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.